Cardiology/Cardiovascular Surgery

Artificial Intelligence- Enabled Quantitative Coronary Plaque and Hemodynamic for Predicting Acute Coronary Syndrome

JAAC: Cardiovascular Imaging

JAAC: Cardiovascular Imaging

Research Authors: Bon-Kwon Koo, Seokhun Yang, Jae Wook Jung, Jinlong Zhang, Keehwan Lee, Doyeon Hwang, Kyu-Sun Lee, Joon-Hyung Doh, Chang-Wook Nam, Tae Hyun Kim, Eun-Seok Shin, Eun Ju Chun, Su-Yeon Choi, Hyun Kuk Kim, Young Joon Hong, Hun-Jun Park, Song-Yi Kim, Mirza Husic, Jess Lambrechtsen, Jesper M Jensen, Bjarne L Nørgaard, Daniele Andreini, Pal Maurovich-Horvat, Bela Merkely, Martin Penicka , Bernard de Bruyne, Abdul Ihdayhid , Brian Ko, Georgios Tzimas, Jonathon Leipsic, Javier Sanz , Mark G Rabbat , Farhan Katchi , Moneal Shah , Nobuhiro Tanaka , Ryo Nakazato, Taku Asano , Mitsuyasu Terashima, Hiroaki Takashima, Tetsuya Amano , Yoshihiro Sobue, Hitoshi Matsuo, Hiromasa Otake , Takashi Kubo, Masahiro Takahata, Takashi Akasaka, Teruhito Kido, Teruhito Mochizuki, Hiroyoshi Yokoi , Taichi Okonogi, Tomohiro Kawasaki, Koichi Nakao, Tomohiro Sakamoto, Taishi Yonetsu, Tsunekazu Kakuta, Yohei Yamauchi, Jeroen J Bax, Leslee J Shaw, Peter H Stone, Jagat Narula

Research Authors: Bon-Kwon Koo, Seokhun Yang, Jae Wook Jung, Jinlong Zhang, Keehwan Lee, Doyeon Hwang, Kyu-Sun Lee, Joon-Hyung Doh, Chang-Wook Nam, Tae Hyun Kim, Eun-Seok Shin, Eun Ju Chun, Su-Yeon Choi, Hyun Kuk Kim, Young Joon Hong, Hun-Jun Park, Song-Yi Kim, Mirza Husic, Jess Lambrechtsen, Jesper M Jensen, Bjarne L Nørgaard, Daniele Andreini, Pal Maurovich-Horvat, Bela Merkely, Martin Penicka , Bernard de Bruyne, Abdul Ihdayhid , Brian Ko, Georgios Tzimas, Jonathon Leipsic, Javier Sanz , Mark G Rabbat , Farhan Katchi , Moneal Shah , Nobuhiro Tanaka , Ryo Nakazato, Taku Asano , Mitsuyasu Terashima, Hiroaki Takashima, Tetsuya Amano , Yoshihiro Sobue, Hitoshi Matsuo, Hiromasa Otake , Takashi Kubo, Masahiro Takahata, Takashi Akasaka, Teruhito Kido, Teruhito Mochizuki, Hiroyoshi Yokoi , Taichi Okonogi, Tomohiro Kawasaki, Koichi Nakao, Tomohiro Sakamoto, Taishi Yonetsu, Tsunekazu Kakuta, Yohei Yamauchi, Jeroen J Bax, Leslee J Shaw, Peter H Stone, Jagat Narula

AIIM Authors: Gabby Mendelsohn, Amine Noureddine

AIIM Authors: Gabby Mendelsohn, Amine Noureddine

Publication Date: May 15, 2024

Publication Date: May 15, 2024

Comprehensive Summary

In the study, Koo et. al analyzed the value and ability of a type of A.I detention technology (AI-QCPHA) to identify hemodynamic and plaque characteristics of possible ACS (Acute coronary syndrome) cases. Patients that underwent a CTA test (Coronary Computed Tomography Angiography) at least 3 months to 1 year from the start of the ACS study were selected for this study. From data based on given ICA (invasive coronary angiography) and CTA imaging exam, every found lesion from each patient was sorted into two groups: culprit and non culprit. A standardization data set (Coronary Artery Disease Reporting and Data System) for high-risk plaque evaluation (lesions with ≥2 APCs (adverse plaque characteristics)) was used as a reference. This reference document was compared to the same model with additional AI-QCPHA elements. Out of 351 patients in total (average age of 65.9±11.7 years with 223 patients presenting myocardial infarction issues), 243 patients were sorted in the derivation while 108 in the validation group. From the results, the most effective AI-QCPHA features (using data from the derivation cohort) included plaque burden and total volume, fractional flow reverse in lesion, and average percent total myocardial blood flow. Overall, as evident by the data collected in the both the derivation (AUC: 0.86 vs 0.76; P < 0.001) and validation cohorts (AUC: 0.84 vs 0.78; P < 0.001), the AI-QCPHA software showed a higher level of predictability when compared to the reference data.

Outcomes and Implications

Given that acute coronary syndrome (ACS) is one of the main causes of mortality worldwide, risk prediction and early diagnosis is essential. While CTA imaging is the most common diagnostic test for coronary artery disease, due to its low positive predictive measurements in clinic practices, additional features found in the AI-QCPHA technology can substantially improve predictions of ACS diagnosing and provide further prognostic details. With this, physicians can better identify high-risk lesions for ACS. Yet, additional research can still be done to analyze the effective of different treatments to prevent severe lesions from further development.

Our mission is to

Connect medicine with AI innovation.

No spam. Only the latest AI breakthroughs, simplified and relevant to your field.

Our mission is to

Connect medicine with AI innovation.

No spam. Only the latest AI breakthroughs, simplified and relevant to your field.

Our mission is to

Connect medicine with AI innovation.

No spam. Only the latest AI breakthroughs, simplified and relevant to your field.

AIIM Research

Articles

© 2025 AIIM. Created by AIIM IT Team

AIIM Research

Articles

© 2025 AIIM. Created by AIIM IT Team

AIIM Research

Articles

© 2025 AIIM. Created by AIIM IT Team